New book on ‘Philadelphia Chromosome’ ties targeted cancer medicine to the region

    Friday marks the 12-year anniversary of the FDA approval of the drug Gleevec, which has been helping some cancer patients hold the disease in check. The development of so-called “targeted medicines” is a much older story that traces back to our region.

    It’s the topic of a new book called “The Philadelphia Chromosome: A Mutant Gene and the Quest to Cure Cancer at the Genetic Level,” by science journalist Jessica Wapner, who joined NewsWorks Tonight host Dave Heller to talk about the history of the science.

    Want a digest of WHYY’s programs, events & stories? Sign up for our weekly newsletter.

    It will take 126,000 members this year for great news and programs to thrive. Help us get to 100% of the goal.